{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T21:22:20Z","timestamp":1774905740569,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX24_1848"],"award-info":[{"award-number":["KYCX24_1848"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071165"],"award-info":[{"award-number":["32071165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870895"],"award-info":[{"award-number":["31870895"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115391","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:17:00Z","timestamp":1755695820000},"page":"115391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Fraxetin inhibits TNF\u03b1-mediated synoviocyte activation and attenuates disease progression in a rat model of rheumatoid arthritis"],"prefix":"10.1016","volume":"164","author":[{"given":"Yuhang","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyi","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehua","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junnan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.intimp.2025.115391_bb0005","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115391_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res"},{"issue":"11","key":"10.1016\/j.intimp.2025.115391_bb0015","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.3390\/cells10112857","article-title":"Management of Rheumatoid Arthritis: an overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.intimp.2025.115391_bb0020","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s40265-017-0835-9","article-title":"Tofacitinib: a review in rheumatoid arthritis","volume":"77","author":"Dhillon","year":"2017","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.intimp.2025.115391_bb0025","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5114\/reum.2020.102006","article-title":"Baricitinib for the treatment of rheumatoid arthritis","volume":"58","author":"Urits","year":"2020","journal-title":"Reumatologia"},{"issue":"7","key":"10.1016\/j.intimp.2025.115391_bb0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/14728222.12.7.795","article-title":"MAPK phosphatases as novel targets for rheumatoid arthritis","volume":"12","author":"Ralph","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"issue":"10","key":"10.1016\/j.intimp.2025.115391_bb0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc4000","article-title":"MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road","volume":"15","author":"Caunt","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2025.115391_bb0040","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1158\/1078-0432.CCR-08-0333","article-title":"Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway","volume":"14","author":"Sebolt-Leopold","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.115391_bb0045","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000493390","article-title":"Rheumatoid arthritis: a brief overview of the treatment","volume":"27","author":"Bullock","year":"2018","journal-title":"Med. Princ. Pract."},{"issue":"8","key":"10.1016\/j.intimp.2025.115391_bb0050","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/13543776.2017.1339688","article-title":"MEK inhibitors in oncology: a patent review (2015-present)","volume":"27","author":"Mahapatra","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.intimp.2025.115391_bb0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1248\/bpb.29.119","article-title":"Bone morphogenetic protein-2 and -4 (BMP-2 and -4) mediates fraxetin-induced maturation and differentiation in human osteoblast-like cell lines","volume":"29","author":"Kuo","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.intimp.2025.115391_bb0060","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.intimp.2006.02.010","article-title":"Fraxetin inhibits the induction of anti-Fas IgM, tumor necrosis factor-alpha and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63","volume":"6","author":"Kuo","year":"2006","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115391_bb0065","first-page":"1257","article-title":"Inhibition of osteoclastogenesis for periprosthetic osteolysis therapy through the suppression of p38 signaling by fraxetin","volume":"42","author":"Liao","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115391_bb0070","first-page":"7374","article-title":"Effect of fraxetin on proliferation and apoptosis in breast cancer cells","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.intimp.2025.115391_bb0075","doi-asserted-by":"crossref","first-page":"105777","DOI":"10.1016\/j.biocel.2020.105777","article-title":"Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2\/signal transducer and activator of transcription 3 signalling pathway","volume":"125","author":"Ren","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115391_bb0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/pharmaceutics13010112","article-title":"Fraxetin suppresses cell proliferation and induces apoptosis through mitochondria dysfunction in human hepatocellular carcinoma cell lines Huh7 and Hep3B","volume":"13","author":"Song","year":"2021","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.intimp.2025.115391_bb0085","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jsps.2020.09.016","article-title":"Fraxetin inhibits interleukin-1beta-induced apoptosis, inflammation, and matrix degradation in chondrocytes and protects rat cartilage in vivo","volume":"28","author":"Wang","year":"2020","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.intimp.2025.115391_bb0090","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39(Web Server issue), W270-277","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.intimp.2025.115391_bb0095","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2025.115391_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2023.104844","article-title":"Phillyrin ameliorated collagen-induced arthritis through inhibition of NF-\u03baB and MAPKs pathways in fibroblast-like synoviocytes","volume":"16","author":"Chen","year":"2023","journal-title":"Arab. J. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2025.115391_bb0105","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/ptr.8205","article-title":"Sophoridine exerts anti-arthritic effects on fibroblast-like synoviocytes and collagen-induced arthritis in rats","volume":"38","author":"Chen","year":"2024","journal-title":"Phytother. Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115391_bb0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11626-023-00810-1","article-title":"In vitro inhibitory effect of zingerone on TNFalpha-stimulated fibroblast-like synoviocytes","volume":"59","author":"Mao","year":"2023","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"5","key":"10.1016\/j.intimp.2025.115391_bb0115","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3390\/ijms19051514","article-title":"Jatrorrhizine hydrochloride suppresses proliferation, migration, and secretion of Synoviocytes in vitro and ameliorates rat models of rheumatoid arthritis in vivo","volume":"19","author":"Qiu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115391_bb0120","doi-asserted-by":"crossref","first-page":"670707","DOI":"10.3389\/fphar.2021.670707","article-title":"Tomatidine suppresses the destructive Behaviors of fibroblast-like Synoviocytes and ameliorates type II collagen-induced arthritis in rats","volume":"12","author":"Yu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115391_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109181","article-title":"Peimine suppresses collagen-induced arthritis, activated fibroblast-like synoviocytes and TNFalpha-induced MAPK pathways","volume":"111","author":"Zhou","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115391_bb0130","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1002\/jcp.26754","article-title":"Inhibitory effects of tubeimoside I on synoviocytes and collagen-induced arthritis in rats","volume":"233","author":"Liu","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115391_bb0135","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/10717544.2022.2056662","article-title":"Selective delivery of curcumin to breast cancer cells by self-targeting apoferritin nanocages with pH-responsive and low toxicity","volume":"29","author":"Ji","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.intimp.2025.115391_bb0140","doi-asserted-by":"crossref","first-page":"869794","DOI":"10.3389\/fphar.2022.869794","article-title":"Ferrostatin-1 ameliorates liver dysfunction via reducing Iron in thioacetamide-induced acute liver injury in mice","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115391_bb0145","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/jat.4258","article-title":"PFOS facilitates liver inflammation and steatosis: an involvement of NLRP3 inflammasome-mediated hepatocyte pyroptosis","volume":"42","author":"Qin","year":"2022","journal-title":"J. Appl. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115391_bb0150","doi-asserted-by":"crossref","first-page":"802","DOI":"10.5530\/ijper.57.3.98","article-title":"Combination of N-acetyl cysteine and thymoquinone alleviates hepatocellular toxicities by radiation and CCl","volume":"57","author":"Zhang","year":"2023","journal-title":"Indian J. Pharm. Educ. Res."},{"issue":"34","key":"10.1016\/j.intimp.2025.115391_bb0155","doi-asserted-by":"crossref","first-page":"29868","DOI":"10.1021\/acsomega.2c02766","article-title":"Imperatorin inhibits proliferation, migration, and inflammation via blocking the NF-kappaB and MAPK pathways in rheumatoid fibroblast-like Synoviocytes","volume":"7","author":"Lin","year":"2022","journal-title":"ACS Omega"},{"issue":"6141","key":"10.1016\/j.intimp.2025.115391_bb0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.intimp.2025.115391_bb0165","first-page":"228","article-title":"Assessing plasma lipid levels, body weight, and hepatic and renal toxicity following chronic oral administration of a water soluble phytostanol compound, FM-VP4, to gerbils","volume":"4","author":"Wasan","year":"2001","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115391_bb0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13018-022-03006-7","article-title":"The protective effect of gentisic acid on rheumatoid arthritis via the RAF\/ERK signaling pathway","volume":"17","author":"Dong","year":"2022","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.intimp.2025.115391_bb0175","doi-asserted-by":"crossref","DOI":"10.1177\/2058739218794531","article-title":"Inhibition of ERK pathway decreases the synovial hyperplasia and angiogenesis of rheumatoid arthritis rats","volume":"16","author":"Hu","year":"2018","journal-title":"Eur. J. Inflamm."},{"issue":"5","key":"10.1016\/j.intimp.2025.115391_bb0180","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3892\/etm.2022.11620","article-title":"Chemerin promotes MAPK\/ERK activation to induce inflammatory factor production in rat synoviocytes","volume":"24","author":"Wang","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115391_bb0185","doi-asserted-by":"crossref","DOI":"10.4081\/mk.2015.5508","article-title":"Clinical candidates of small molecule p38 MAPK inhibitors for inflammatory diseases","volume":"4","author":"Xing","year":"2015","journal-title":"MAP Kinase"},{"issue":"9","key":"10.1016\/j.intimp.2025.115391_bb0190","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/154405910708600902","article-title":"p38 pathway kinases as anti-inflammatory drug targets","volume":"86","author":"Schindler","year":"2007","journal-title":"J. Dent. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.115391_bb0195","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/art.24485","article-title":"Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies","volume":"60","author":"Damjanov","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.intimp.2025.115391_bb0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13018-020-01595-9","article-title":"The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3","volume":"15","author":"Kanai","year":"2020","journal-title":"J. Orthop. Surg. Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115391_bb0205","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/ar2215","article-title":"Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes","volume":"9","author":"Hammaker","year":"2007","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2025.115391_bb0210","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.3390\/cimb45040197","article-title":"Rheumatoid arthritis and reactive oxygen species: a review","volume":"45","author":"Kondo","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115391_bb0215","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jb\/mvn172","article-title":"Blockage by SP600125 of Fcepsilon receptor-induced degranulation and cytokine gene expression in mast cells is mediated through inhibition of phosphatidylinositol 3-kinase signalling pathway","volume":"145","author":"Tanemura","year":"2009","journal-title":"J. Biochem."},{"issue":"5","key":"10.1016\/j.intimp.2025.115391_bb0220","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00011-011-0431-5","article-title":"Suppressive effect of an orally active MEK1\/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide","volume":"61","author":"Yamaguchi","year":"2012","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.115391_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2023-255958","article-title":"Large-vessel vasculitis possibly induced by BRAF and MEK inhibitors for BRAF V600E positive lung adenocarcinoma","volume":"17","author":"Ichikawa","year":"2024","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.intimp.2025.115391_bb0230","doi-asserted-by":"crossref","first-page":"v897","DOI":"10.1093\/annonc\/mdz394.058","article-title":"LBA61 - a randomized phase II\/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer","volume":"30","author":"Gershenson","year":"2019","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115391_bb0235","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1158\/1535-7163.MCT-11-1010","article-title":"ERK inhibition overcomes acquired resistance to MEK inhibitors","volume":"11","author":"Hatzivassiliou","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.intimp.2025.115391_bb0240","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules22101551","article-title":"Current development status of MEK inhibitors","volume":"22","author":"Cheng","year":"2017","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.intimp.2025.115391_bb0245","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrclinonc.2014.83","article-title":"The clinical development of MEK inhibitors","volume":"11","author":"Zhao","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.115391_bb0250","doi-asserted-by":"crossref","first-page":"102137","DOI":"10.1016\/j.ctrv.2020.102137","article-title":"MEK inhibitor resistance mechanisms and recent developments in combination trials","volume":"92","author":"Kun","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"10086","key":"10.1016\/j.intimp.2025.115391_bb0255","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.intimp.2025.115391_bb0260","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115391_bb0265","first-page":"15","article-title":"Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview, Immun","volume":"16","author":"Ilesanmi-Oyelere","year":"2019","journal-title":"Ageing"},{"issue":"2","key":"10.1016\/j.intimp.2025.115391_bb0270","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jcb.30187","article-title":"Fraxetin induces cell death in colon cancer cells via mitochondria dysfunction and enhances therapeutic effects in 5-fluorouracil resistant cells","volume":"123","author":"Lee","year":"2022","journal-title":"J. Cell. Biochem."},{"issue":"14","key":"10.1016\/j.intimp.2025.115391_bb0275","doi-asserted-by":"crossref","first-page":"18545","DOI":"10.18632\/aging.203301","article-title":"The anti-dysenteric drug fraxetin enhances anti-tumor efficacy of gemcitabine and suppresses pancreatic cancer development by antagonizing STAT3 activation","volume":"13","author":"Guo","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.intimp.2025.115391_bb0280","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1573412913666170525123017","article-title":"HPLC-MS\/MS determination of fraxetin in rat plasma and its application to a pharmacokinetic study","volume":"14","author":"Wang","year":"2018","journal-title":"Curr. Pharm. Anal."},{"issue":"3","key":"10.1016\/j.intimp.2025.115391_bb0285","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1208\/s12249-021-01940-z","article-title":"Preparation of fraxetin long circulating liposome and its anti-enteritis effect","volume":"22","author":"Miao","year":"2021","journal-title":"AAPS PharmSciTech"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925013827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925013827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:50:33Z","timestamp":1762552233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925013827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":57,"alternative-id":["S1567576925013827"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115391","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fraxetin inhibits TNF\u03b1-mediated synoviocyte activation and attenuates disease progression in a rat model of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115391"}}